For the quarter ending 2026-03-31, VERA has $621,739K in assets. $122,042K in debts. $114,351K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 114,351 | 354,725 | 57,773 | 49,121 |
| Marketable securities | 482,409 | 359,864 | 439,616 | 507,706 |
| Prepaid expenses and other assets, current | 19,042 | 14,294 | 13,922 | 14,527 |
| Total current assets | 615,802 | 728,883 | 511,311 | 571,354 |
| Property and equipment, net | - | 1,374 | 1,155 | 1,151 |
| Operating lease right-of-use assets | - | 1,923 | 2,036 | 2,471 |
| Prepaid expenses and other assets, noncurrent | - | 2,553 | 3,001 | 3,552 |
| Other assets, noncurrent | 5,937 | - | - | - |
| Total assets | 621,739 | 734,733 | 517,503 | 578,528 |
| Operating lease liabilities | - | 549 | 473 | 855 |
| Accounts payable | 13,909 | 21,898 | 17,950 | 13,157 |
| Accrued expenses and other liabilities, current | 31,240 | 31,008 | 23,457 | 19,542 |
| Total current liabilities | 45,149 | 53,455 | 41,880 | 33,554 |
| Long-term debt | 75,029 | 74,838 | 74,648 | 74,464 |
| Operating lease liabilities, noncurrent | - | 1,919 | 2,095 | 2,233 |
| Other liabilities, noncurrent | 1,864 | - | - | - |
| Total liabilities | 122,042 | 130,212 | 118,623 | 110,251 |
| Class a common stock, 0.001 par value 500,000,000 shares authorized as of march 31, 2026 and december 31, 2025 71,730,090 and 71,267,429 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 72 | 71 | 64 | 64 |
| Additionalpaid-incapital | 1,381,678 | 1,364,529 | 1,067,703 | 1,057,161 |
| Accumulated other comprehensive (loss) income | -156 | 786 | 881 | 527 |
| Accumulated deficit | -881,897 | -760,865 | -669,768 | -589,475 |
| Total stockholders' equity | 499,697 | 604,521 | 398,880 | 468,277 |
| Total liabilities and stockholders' equity | 621,739 | 734,733 | 517,503 | 578,528 |
Vera Therapeutics, Inc. (VERA)
Vera Therapeutics, Inc. (VERA)